MLN Connects® Provider eNews for May 14, 2015
View this edition as a PDF
In This Edition:
MLN Connects® National Provider Calls
- 2014 Mid-Year QRURs — Register Now
- Medicare Shared Savings Program ACO: Application Review — Registration Now Open
- National Partnership to Improve Dementia Care and QAPI — Register Now
- Hospice Quality and Hospice Item Set Manual V1.02 — Save the Date
- ICD-10: Preparing for Implementation and New ICD-10-PCS Section X — Register Now
MLN Connects® Videos
- New ICD-10 Videos: Impact on Inpatient Hospital Payment and Medicare Testing Plans
- Final Opportunity to Volunteer for ICD-10 End-to-End Testing in July — Forms Accepted May 11 through 22
- Participate in Final ICD-10 Acknowledgement Testing Week: June 1 through 5
- Special Open Door Forum: Home Health Electronic and Paper Clinical Templates
- Depression is Not a Normal Part of Growing Older
- Therapy Caps Exceptions Process Extended through CY 2017
- Questions about Medicare?
- Notices of Intent to Apply for Medicare Shared Savings Program January 1, 2016, Start Date Due by May 29
- Groups: 6 Weeks Left to Register for 2015 PQRS GPRO
Medicare Learning Network® Educational Products
- “Overview of the Repetitive Scheduled Non-emergent Ambulance Prior Authorization Model” MLN Matters® Article — Released
- “Items and Services That Are Not Covered Under the Medicare Program” Booklet — Revised
- Medicare Learning Network® Product Available In Electronic Publication Format
The following JH Draft Local Coverage Determinations (LCDs) are posted for comment. The comment period ends on July 9, 2015. Please note that the Draft LCDs will not become effective until after ICD-10 is implemented. Therefore, all Draft LCDs are in ICD-10 format.
- Cardiovascular Nuclear Medicine (DL35083)
- Controlled Substance Monitoring and Drugs of Abuse Testing (DL35006)
- Cosmetic and Reconstructive Surgery (DL35090)
- Hyperbaric Oxygen (HBO) Therapy (DL35021)
- In Vitro Chemosensitivity & Chemoresistance Assays (DL36055)
- Loss of Heterozygosity Based Topographic Genotyping with PathfinderTG® (DL34864)
- Mohs Micrographic Surgery (DL34961)
- Psychiatric Codes (DL35101)
- Transesophageal Echocardiography (TEE) (DL35016)
The following JH Local Coverage Determinations (LCDs) have been revised:
- Hemophilia Factor Products (L33658)
- Hyperbaric Oxygen (HBO) Therapy (L32739)
- Treatment of Varicose Veins and Venous Stasis Disease of the Lower Extremities (L32678)
The following JH Local Coverage Provider Bulletin has been retired effective May 6, 2015. For dates of service on and after May 7, 2015, please reference Article A54099, Compounded Drugs Used in an Implantable Infusion Pump.
- Part B Compounded Drugs Used in an Implantable Infusion Pump-Provider Bulletin (A52751)
Registration Available for May 28, 2015 Open Meeting and Draft LCDs Now Posted
Registration for the May 28, 2015 Open Meeting is now available. Registration will be closed at the end of business day on Tuesday, May 26, 2015. Novitas Solutions’ draft LCDs are also now posted.
Please note that the Novitas Solutions Open Meeting is a combined meeting for both Medicare Administrative Contractor (MAC) Jurisdiction H (JH) and MAC Jurisdiction L (JL) contract areas.
Open Meetings are for the purpose of discussing draft Local Coverage Determinations (LCDs). Anyone is welcome to present information related to the policies that are in the 45-day draft comment period. Interested participants may request to present scientific, evidence-based information; professional consensus opinions; or any other information that is relevant to any of the LCDs that are in draft. These in-person presentations are made to the Novitas Solutions’ Contractor Medical Directors. Interested parties may also request to attend as an observer.
NOTE: The Open Meeting is not a forum for discussing specific claims; or for the submission of new drugs, indications, or marketing of forthcoming drugs or medical devices. Information regarding new drugs, indications, or marketing information should be submitted according to Novitas guidelines. Specific claim questions, including billing, pricing and coding, should be directed to our Customer Service Center at 1-855-252-8782.
NOTE: The Open Meeting is not a forum for discussing specific claims; or for the submission of new drugs, indications, or marketing of forthcoming drugs or medical devices. Information regarding new drugs, indications, or marketing information should be submitted according to Novitas guidelines. Specific claim questions, including billing, pricing and coding, should be directed to our Customer Service Center at 1-855-252-8782.
